Anti-Hmgb1 Antibodies and Alpha-7 Agonists as Experimental Therapeutics as BW Countermeasures

doi 10.21236/ada459623
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center